A Systematic Review on Intrapyloric Botulinum Toxin Injection for Gastroparesis

Background: Though trials evaluating the effect of intrapyloric botulinum toxin injection on gastroparesis have been reported, there is no agreement whether botulinum toxin can effectively relieve the symptoms and improve the results of gastric emptying study in patients with gastroparesis. We performed a systematic literature review to address this issue. Methods: Databases including PubMed, EMBASE, and the Cochrane Library and Science Citation Index were searched. Two reviewers independently identified relevant trials. Outcome measures were the improvement of subjective symptoms and objective measurement. Results: 15 reports were included; only 2 randomized controlled trials were available. Almost all the non-randomized trials reported significant improvement in subjective symptoms and objective gastric emptying study after botulinum toxin injection. While the 2 randomized controlled trials did not confirm the efficacy of botulinum toxin injection, none of the individual trials showed that there was statistically significant subjective and objective improvement in the active patients when compared with patients receiving placebo. Conclusions: Available high-quality trials showed that intrapyloric botulinum toxin injection could not significantly relieve subjective symptoms and improve objective measurement in patients with gastroparesis, and there is no evidence to recommend botulinum toxin injection for the treatment of gastroparesis.

[1]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[2]  Hye-Kyung Jung,et al.  Incidence , Prevalence , and Outcomes of Patients With Gastroparesis n Olmsted County , Minnesota , From 1996 to 2006 , 2022 .

[3]  Michelle A. Anderson,et al.  Factors Associated with Symptom Response to Pyloric Injection of Botulinum Toxin in a Large Series of Gastroparesis Patients , 2009, Digestive Diseases and Sciences.

[4]  P. Pasricha,et al.  A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  M. Abouzari,et al.  Pyloric Injection of Botulinum Toxin for the Treatment of Refractory GERD Accompanied with Gastroparesis: A Preliminary Report , 2008, Digestive Diseases and Sciences.

[6]  A. Hanlon,et al.  Botulinum Toxin A for the Treatment of Delayed Gastric Emptying , 2008, The American Journal of Gastroenterology.

[7]  Yu Bai,et al.  Prophylactic Antibiotics Cannot Reduce Infected Pancreatic Necrosis and Mortality in Acute Necrotizing Pancreatitis: Evidence From a Meta-Analysis of Randomized Controlled Trials , 2008, The American Journal of Gastroenterology.

[8]  R. Bisschops,et al.  Clinical trial: a randomized‐controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis , 2007, Alimentary pharmacology & therapeutics.

[9]  G. Porro,et al.  Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study , 2007, International Journal of Obesity.

[10]  M. Srougi,et al.  Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia , 2007, Nature Clinical Practice Urology.

[11]  M. Camilleri,et al.  Clinical practice. Diabetic gastroparesis. , 2007, The New England journal of medicine.

[12]  K. Verbeke,et al.  Influence of intrapyloric botulinum toxin injection on gastric emptying and meal‐related symptoms in gastroparesis patients , 2006, Alimentary pharmacology & therapeutics.

[13]  L. Spahr,et al.  Acute delayed gastric emptying after ablation of atrial fibrillation: treatment with botulinum toxin injection. , 2006, Endoscopy.

[14]  E. Melzer,et al.  Successful treatment of gastroparesis following total esophagectomy using botulinum toxin. , 2006, Endoscopy.

[15]  P. Baron,et al.  Intrapyloric Injection of Botulinum Toxin A for the Treatment of Persistent Gastroparesis Following Successful Pancreas Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  R. Fisher,et al.  Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. , 2005, Gastrointestinal endoscopy.

[17]  C. Montecucco,et al.  Botulinal neurotoxins: revival of an old killer. , 2005, Current opinion in pharmacology.

[18]  R. Fisher,et al.  American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. , 2004, Gastroenterology.

[19]  R. Fisher,et al.  American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. , 2004, Gastroenterology.

[20]  R. Spicer,et al.  Intrapyloric botulinum toxin injection improves gastric emptying. , 2003, Journal of pediatric gastroenterology and nutrition.

[21]  D. Revicki,et al.  Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index , 2003, Alimentary pharmacology & therapeutics.

[22]  Michael P. Jones,et al.  Oral Erythromycin and Symptomatic Relief of Gastroparesis: A Systematic Review , 2003, American Journal of Gastroenterology.

[23]  Satish S. C. Rao,et al.  Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. , 2002, Gastrointestinal endoscopy.

[24]  R. Fisher,et al.  Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle , 2002, American Journal of Gastroenterology.

[25]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[26]  M. Bhutani,et al.  Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. , 2002, Gastrointestinal endoscopy.

[27]  M. Crowell,et al.  Botulinum toxin for the treatment of gastroparesis: a preliminary report , 2002, American Journal of Gastroenterology.

[28]  P. Pasricha,et al.  The treatment of diabetic gastroparesis with botulinum toxin , 2000, American Journal of Gastroenterology.

[29]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[30]  R. Fisher,et al.  Use of Botulinum Toxin in the Treatment of Achalasia , 1998, Digestive Diseases.

[31]  G. Barbara,et al.  Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. , 1996, Gastroenterology.

[32]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[33]  P. Pasricha,et al.  Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. , 1993, Gastroenterology.

[34]  D L Demets,et al.  Methods for combining randomized clinical trials: strengths and limitations. , 1987, Statistics in medicine.

[35]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[36]  M. Camilleri,et al.  Pyloric dysfunction in diabetics with recurrent nausea and vomiting. , 1986, Gastroenterology.

[37]  J. Luketich,et al.  A pilot study of botulinum toxin injection for the treatment of delayed gastric emptying following esophagectomy , 2007, Surgical Endoscopy.

[38]  P. Macmathuna,et al.  Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. , 2006, The Cochrane database of systematic reviews.

[39]  Michael P. Jones,et al.  A systematic review of surgical therapy for gastroparesis , 2003, American Journal of Gastroenterology.